The immunoglobulin (Ig) heavy chain (IgH) locus is composed of tandem organized gene segments, V H , D H , and J H , plus the constant region exons. Consecutive D-J and V-DJ recombination events during B-cell development form the mature VDJ (antigen binding) exon, and it is the combinatorial association of these segments and the imprecise joining at the junctions that accounts for a great part of the diversity of the antibody repertoire. Each V gene segment contains a promoter that will express the mature recombined Ig transcript, a small leader exon encoding the signal peptide, and the 5Ј-most portion of the Ig coding sequence. V gene segments in the murine IgH locus are classified into approximately 15 families, with each family defined by 80% or more coding sequence identity. Downstream of the D H and J H segments are the intronic enhancer (termed E ), the Ig constant regions, and other regulatory sequences.
Studies have shown that non-protein-coding transcripts from the V region promoters can be detected prior to recombination (1, 14, 59 ; reviewed in reference 49). These RNAs are termed sterile or germ line transcripts. Several studies have shown that expression of germ line transcripts roughly correlates with the occurrence of V-DJ recombination (24, 41, 59 ), suggesting a model in which germ line transcription promotes V-DJ recombination. However, other studies have shown that recombination efficiency does not always reflect promoter strength (1, 25) . Most likely, a combination of promoter activity, proximity to the DJ gene segments, strength of the recombination signal sequence, and the timing and extent of chromatin opening accounts for the pattern of IgH recombination in B cells.
In isolation, V H region promoter activity is specific to cells of the lymphoid lineage, especially B lymphocytes (for recent reviews, see references 16, 28, and 33) . However, the molecular basis of this selective IgH promoter expression is incompletely understood. Although several regulatory motifs, including E boxes, Ets sites, C/EBP binding sites, and pyrimidine-rich sequences have been shown to contribute to promoter activity in specific V region promoters (6, 8, 15, 45) , a DNA element known as the octamer motif (5Ј-ATGCAAAT-3Ј) appears to be the critical determinant of Ig promoter B-cell specificity (3, 9, 27, 29) . The octamer is present in most Ig promoters (34) ; however, this same motif often occurs in the regulatory regions of other genes, many of which are non-B-cell specific. Examples include the regulatory regions of the U1 and U6 snRNA and histone H2B genes (30, 48) . Furthermore, the known trans-acting factors that interact with the octamer element also cannot account for the B-cell specificity. Three of these factors are present in B cells: Oct-1, Oct-2, and OCA-B/Bob-1/OBF-1.
Oct-1 (47, 52, 55 ) is a founding member of the POU domain family of transcription factors (17) that recognizes the octamer motif and related sequences. Oct-1 is conjectured to be preferentially active at Ig promoters (36, 46 ), yet it is ubiquitously expressed in adult cells.
Oct-2 (5, 39, 51) is another POU domain protein capable of binding the octamer motif with similar affinity and specificity. It and the coactivator OCA-B/Bob-1/OBF-1 (13, 26, 54) have a more-B-cell-restricted expression pattern, but data from mouse knockout studies indicate that neither is required for early B-cell development and Ig transcription (7, 10, 19, 32, 43) . The Oct-2/OCA-B double knockout has also been reported to produce B cells that express Ig (44) . Consistent with these results, data from several laboratories indicate that physiological levels of Oct-2 and OCA-B fail to activate Ig promoters and that instead they act preferentially at the IgH intronic and 3Ј enhancer regions (36, 53, 57, 58) .
We have used an in vivo approach in order to find and characterize additional cis regions and trans factors that mediate B-cell-specific IgH promoter transcription. In this ap-proach, changes in IgH promoter activity were measured as changes in the amount of green fluorescent protein (GFP) produced from a cDNA linked to an IgH promoter (17.2.25; see Materials and Methods). Cells with increased GFP activity were monitored, enriched, and isolated using fluorescenceactivated cell sorting (FACS).
During the course of these experiments, we observed that one murine pre-T-cell line, 2017 (50), could be selected to have levels of GFP that are 100-fold higher than the baseline. Several clones from this high-GFP population have been isolated and further characterized. We also report the delineation of a new cis-acting element downstream of the transcription initiation site in IgH promoters and the promoters of several other B-cell-specific genes.
MATERIALS AND METHODS
Transfection constructs. DNA used for transfection was double-band CsCl purified (38) . Unless otherwise noted, the murine 17.2.25 hybridoma heavy chain promoter was used in Ig promoter analyses and in the formation of stable cell lines. For the luciferase constructs, the pGL3 basic vector (Promega) was digested with BglII and HindIII, treated with alkaline phosphatase, and gel purified. The plasmid p⌬1 (12) was used as a PCR template with PCR primers containing restriction enzyme sites on their 5Ј ends. p⌬1 PCR products were digested with BglII and HindIII, gel purified, and ligated into the pGL3 backbone using T4 DNA ligase (Life Technologies). The full-length IgH promoter corresponded to residues from Ϫ154 to ϩ35 relative to the transcription initiation site. The sequence of the IgH-154Bgl 5Ј primer used to amplify the promoter sequences was 5Ј-GGAGATCTGGATCCAGAGTTNGG-3Ј. The sequences of the 3Ј primers were as follows: IgH ϩ 35Hind, 5Ј-GGAAGCTTGAGATTCAG TGTCT-3Ј; and IgH ϩ 1Hind, 5Ј-GGAACGTTATGATGTTTGGTGTG-3Ј. For the H2B promoter constructs, two oligonucleotides containing sequences from the human H2B promoter (48) were synthesized with phosphate groups on their 5Ј ends. The oligonucleotides were as follows: H2B-595ЈBgl, 5Ј-GATCTT CTTCACCTTATTTGCATAAGCGATTCTATATAAAAGCGCCTTGTCAT ACCCTACTCACGA-3Ј; and H2B-593ЈHind, 5Ј-AGCTTCGTGAGTAGGGT ATGACAAGGCGCTTTTATATAGAATCGCTTATGCAAATAAGGTGAA GAA-3Ј. The oligonucleotides were annealed together, creating a doublestranded molecule with BglII-and HindIII-compatible ends, and ligated directly into pGL3. The final portion of the H2B promoter incorporated into the luciferase construct spanned sequences from Ϫ59 to ϩ1 relative to the transcription initiation site. The IgH-154 ϩ 35 construct with the E intronic enhancer was made by inserting a 700-bp enhancer sequence from the EVH186.2 construct (a gift of F. Alt) into a distal pGL3 XbaI site located approximately 2 kb upstream of the promoter sequence. The IgH-154 ϩ 1/186.2 chimeric promoter was made by inserting a double-stranded oligonucleotide with HindIII overhangs and 5Ј phosphate groups into the HindIII site of the IgH-154 ϩ 1 construct. The sequences of the oligonucleotides were as follows: 186.2HinTOP, 5Ј-AGCTTG ATCACTGTTCTCTTTACAGTTACTGAGCACACAGGA-3Ј; and 186.2Hin BOT, 5Ј-AGCTTCCTGTGTGCTCAGTAACTGTAAAGAGAACAGTGATC A-3Ј. The sequence and orientation of the insert were confirmed by DNA sequencing and PCR.
Construction of the scanning promoter mutagenesis constructs utilized the EcoRV site located at Ϫ21 relative to the transcription initiation site in the 17.2.25 promoter. The full-length Ϫ154 to ϩ35 luciferase construct was digested with EcoRV and HindIII, treated with alkaline phosphatase (Life Technologies), and gel purified. Oligonucleotides (73-mer) containing the promoter sequence between the EcoRV and HindIII sites and containing 3-bp mutations were amplified by seven rounds of PCR using Taq DNA polymerase (Perkin-Elmer) and primers homologous to the 5Ј and 3Ј ends. The mutations were A3C, G3T, C3A, and T3G. As an example, the sequence of the oligonucleotide IgMut-15 was 5Ј-CGCAGCGATATCACAACCAAACATCATATGAGCCCTATCTTCT CTACAGACACTGAATCTCAAGCTTCGAGCC-3Ј. The letters in bold indicate the positions of the mutation. The EcoRV and HindIII sites are underlined. The PCR primers were 5Ј-AGCCGCAGCGATATC-3Ј and 5Ј-AGCGGCTCG AAGCTT-3Ј. The products were digested with EcoRV and HindIII and ligated into the digested Ϫ154 to ϩ35 construct.
For GFP constructs, the pEGFP-1 plasmid (Clontech) was digested with BglII and HindIII, treated with alkaline phosphatase, and gel purified. The luciferase construct (Ϫ154 to ϩ35) was digested with BglII and HindIII, gel purified, and ligated into the pEGFP-1 backbone creating the plasmid pEGFP-IgH-154 ϩ 35.
Cell culture, transfections, and stable cell lines. The cell lines 2017, BJA-B, M12, 70Z/3, and WERI-27 were grown in RPMI with HEPES (Life Technologies) plus 10% heat-inactivated fetal calf serum (IFS) (HyClone), 2 mM Lglutamine, 50 U of penicillin-streptomycin/ml, and 50 M 2-mercaptoethanol. EL-4, p5424, and 4b were grown in Dulbecco's modified Eagle medium with HEPES (Life Technologies), 10% IFS, L-glutamine, penicillin-streptomycin, and 2-mercaptoethanol. When transfections were performed using electroporation, 2 ϫ 10 6 subconfluent cells were harvested and resuspended in 400 l of the appropriate medium without IFS. Ten micrograms of total DNA was added (typically 2 g of luciferase reporter, 2 g of pCMV-␤Gal, and 6 g of pUC18 DNA), and the reaction mixtures were incubated on ice for 10 min. Cells were electroporated with a Bio-Rad Gene Pulser set at 260 V, 960 F, and 200 ⍀ and with cuvettes with a gap length of 4 mm. After a further 10-min incubation on ice, the cells were plated in 10-cm-diameter dishes with 10 ml of complete medium. Cells were harvested and assayed after 24 h. Lipid-mediated transfection experiments used the FuGene6 transfection reagent (Roche) according to the manufacturer's instructions. Total DNA (2.5 g) (typically 500 ng each of the lucif-FIG. 1. Sequence of the 17.2.25 IgH promoter. The sequence was taken from reference 12. Known regulatory sequences, including the heptamer (5Ј-CTCATGA-3Ј), the octamer (5Ј-ATGCAAAT-3Ј), and the TATA region (5Ј-TAATATA-3Ј), are shown in bold. Also shown in bold are the initiating A residue at ϩ1 and the ATG start codon (Met) at ϩ52. Promoter sequences used in this study were cloned to either ϩ1 or ϩ35. Sequences upstream of the heptamer are not shown, but they were present up to Ϫ154. Also noted in brackets is the pyrimidine (Py)-rich motif (12 of 13 pyrimidine residues) centered at ϩ12. , and EL-4 were transfected with either the pGL3 backbone (white bars) or IgH-luciferase promoter constructs containing (IgH-154 ϩ 35) (light gray bars) or lacking (IgH-154 ϩ 1) (dark gray bars) the sequences from the transcription initiation site to ϩ35. pCMV-␤Gal was cotransfected as an internal control. Transfections were performed by electroporation. The luciferase/␤-Gal activity ratio is depicted on the y axis. Averages from three replicate experiments are shown. Error bars denote standard deviations. (B) Promoter constructs containing 3-bp mutants spanning the transcription initiation site were electroporated into either the B-cell line BJA-B (white bars) or the nonlymphoid cell line WERI-27 (dark gray bars). The construct name is shown to the right of the sequence for that construct. The full-length (ϩ35) and deletion (ϩ1) constructs were included as controls. pCMV-␤Gal was cotransfected, and the luciferase/␤-Gal activity ratio is shown on the x axis. The mutations were as follows: A3C, G3T, C3A, and T3G. Note that mutations beginning at ϩ1 and ϩ19 relative to the transcription initiation site are missing in this series. Py, pyrimidine. 
Reverse transcription PCR (RT-PCR).
The Superscript system (Life Technologies) was used. Total RNA was prepared from 5 ml of subconfluent cells using RNAzol (Teltest). GFP-specific primers were as follows: GFP-1, 5Ј-TGAACC GCATCGAGCTGAAGGG-3Ј; GFP-2, 5Ј-TCCAGCAGGACCATGTGATCG C-3Ј. V region-specific primers were as follows: J5585ЈL, 5Ј-TCCTCCTGTCAG TAACTGCAG-3Ј; J5583ЈFWIII, 5Ј-ATGATGGCAGTGCTGGAGGAT-3Ј. For the GFP analysis, reactions were amplified for 24 cycles in an MJ Research PTC 100 thermal cycler. For the V region analysis, reactions were amplified for 39 cycles. After 28 cycles, parallel reaction mixtures containing actin primers (Ambion) were removed to retain the actin amplification in the linear range.
RESULTS
DNA elements downstream of the transcription initiation site are necessary for full promoter activity. The sequence of the murine 17.2.25 IgH promoter (12) is shown in Fig. 1 . Key features of this promoter include the octamer motif centered at Ϫ53 relative to the transcription initiation site, a poor consensus TATA region, and a heptamer site (8) 2 bp upstream of the octamer sequence. The heptamer site is also recognized by Oct proteins (23, 37) . Interestingly, mutation of the TATA sequence to a consensus adenovirus major late promoter TATA sequence reduces promoter activity (35) .
In an initial analysis, we tested the activity of a 190-bp fragment of the promoter by linking it to a luciferase reporter gene and transiently transfecting it into several human and mouse B-and T-cell lines using electroporation (see Materials and Methods). The sequences used contained the octamer motif, TATA region, and 35 residues downstream of the transcription initiation site (Ϫ154 to ϩ35). A promoter construct missing the downstream residues (Ϫ154 to ϩ1) and the backbone plasmid were also used. pCMV-␤Gal was cotransfected as an internal control. The cells were harvested after 24 h and assayed for luciferase and ␤-galactosidase (␤-Gal) activity. Averaged luciferase/␤-Gal activity ratios from three experiments are shown in Fig. 2A . As expected, the luciferase/␤-Gal ratios for the B-cell lines (BJA-B, M12, and 70Z/3) tended to be greater than those for the T-cell lines (4b, P5424, and 2017). The murine T-cell line EL-4, which has been reported to have high IgH promoter activity (36) was the sole exception. Comparing pre-B (70Z/3), mature B (M12), and activated plasma cell lines (BJA-B), we also noted an increase in promoter activity with the full-length promoter construct. These studies indicated the presence of a potential regulatory element located downstream of the transcription initiation site, as removal of the sequences downstream of ϩ1 resulted in an approximately fourfold down-regulation of promoter activity ( Fig. 2A) . The deletion appeared to have a greater effect on cell lines derived from more mature B cells, such as BJA-B and M12, than with earlier stage B-cell lines such as 70Z.
Deletion studies (data not shown) indicated that removal of the sequences downstream of ϩ20 had little effect on promoter activity but that a deletion to ϩ14 resulted in a significant reduction. We therefore undertook a more refined scanning promoter mutagenesis approach in which 3-bp mutations were introduced along the promoter DNA from Ϫ15 to ϩ25 (Fig.  2B ). These mutant constructs were cotransfected with pCMV␤Gal into either the B-cell line BJA-B or the nonlymphoid cell line WERI-27. The wild-type Ϫ154 to ϩ35 and Ϫ154 to ϩ1 constructs were transfected as controls (Fig. 2B ). These studies indicated that mutation of nucleotides ϩ16, ϩ17, and ϩ18 largely eliminated the higher promoter activity of BJA-B cells relative to WERI-27 cells. These residues partially overlapped with a 13-nucleotide pyrimidine-rich sequence centered at ϩ12 (Fig. 1) . Mutating the residues immediately upstream of the transcription initiation site also largely abolished BJA-B-specific promoter activity (Ϫ3, Ϫ2, and Ϫ1) (Fig. 2B) . Point mutation of the ϩ16 to ϩ18 region affected reporter activity more severely than complete deletion, possibly because in the deletion constructs the substituted sequences from the backbone plasmid partially complement the effect of the deletion.
To test whether the downstream sequence determinants can be complemented by sequences from another IgH promoter, a chimeric construct was made in which sequences from the V H 186.2 promoter (see Fig. 8 and reference 20) were placed immediately downstream of the IgH-154 ϩ 1 construct. The final construct contained sequences from the 17.2.25 promoter to ϩ1, a six-nucleotide HindIII site, and the sequence from the 186.2 promoter downstream of the transcription start site from ϩ6 to ϩ42. As shown in Fig. 2C , transient transfection of this construct into BJA-B cells restored full promoter activity.
In the case of the murine pre-T-cell line 2017 (50), the IgH reporter activity from the full-length promoter was weak but measurable relative to that of B-cell lines and EL-4 ( Fig. 2A) . The low level of expression was promoter specific, as control promoters such as the octamer-containing but non-cell-typespecific H2B promoter were highly active in both 2017 and EL-4 (Fig. 2D) . The 2017 cell line is thy-1 positive and expresses Oct-1 and Oct-2 (Oct-2 at low levels) but does not express OCA-B (unpublished data). Transient overexpression of Oct-1 or OCA-B (Fig. 2E) or stable overexpression of Oct-2 (data not shown) did not increase the level of IgH promoter activity in 2017 to that observed with B cells or EL-4. These observations provided evidence that Oct-1, Oct-2, and OCA-B constructs containing the IgH promoter (Ϫ154 ϩ 35) (dark gray bars) or the H2B promoter (Ϫ59 ϩ 1) (white bars). Transfections were performed by electroporation. (E) Averages from three transfection experiments are shown. T-cell lines 2017, EL-4, and 4b were transfected either with the pGL3 vector or with the IgH-154 ϩ 35 reporter construct. In some cases the reporter constructs were cotransfected with expression constructs encoding human Oct-1 (pCG-Oct-1) (56) and OCA-B/Bob1 (pCATCH-Bob-1) (13). pCMV-␤Gal was cotransfected as an internal control. pUC18 was used to equalize the mass of the amount of DNA transfected. Transfections were performed by electroporation. The luciferase/␤-Gal activity ratio is depicted on the y axis. Error bars denote standard deviations. cannot account for the difference in promoter expression between these cell lines. Selection of clones for high IgH promoter-GFP expression. The above findings were reproduced when GFP was used in place of luciferase in transient transfection assays (data not shown). Therefore, stable 2017 cell lines were constructed in which the Ϫ154 ϩ 35 IgH promoter was linked to GFP. The stable cell lines were single-cell cloned and designated 2017-Ig-GFP. Clone no. 9 had modest GFP activity and was used in these experiments. This clone significantly up-regulates GFP activity upon polyethylene glycol-mediated fusion with the Bcell line M12 (not shown), indicating that it is poised to strongly express the stably transfected IgH promoter if transacting factors present in B cells are supplied. Omitting either polyethylene glycol or the M12 cell line from the fusion mixture eliminated the up-regulation.
Using multiple rounds of FACS, rare 2017-IgH-GFP no. 9 cells were selected that expressed GFP more strongly than the parental cell type. Upon selection, cells appeared that expressed GFP 10-to 100-fold more than the parental population (Fig. 3A) . Another 2017-IgH-GFP clone could be similarly selected, indicating that the ability to up-regulate the IgH promoter is intrinsic to the 2017 cell line and not the individual clone used. In contrast, a similarly engineered B-cell line could not be selected, even after multiple rounds of FACS (data not shown). Individual clones from the high-GFP population were designated 2017-IgH-GFP no. 9 m or h depending on the level of GFP expression gated in the final round of sorting (Fig. 3A) . Several single-cell clones derived from this high-GFP population were isolated and analyzed in detail. The cells had a clumped appearance (Fig. 3D and E) and slightly lower growth rates (data not shown). Western blotting revealed no change in the expression of Oct-1, Oct-2, or OCA-B among these cell lines (data not shown). The GFP activity of these cell lines was stable, as they retained their characteristics even after 4 months in continuous culture. However, upon reselection with several rounds of FACS for a low-GFP phenotype, a stable low-GFP population can reemerge (data not shown).
To demonstrate that the GFP reporter is up-regulated at the RNA level, RT-PCR assays were performed with RNA isolated from the original cell line 2017, the parental clone 2017-IgH-GFP no. 9, and the high-GFP-selected clone h3. The primers used were predicted to amplify a 307-bp portion of the GFP cDNA. The results shown in Fig. 4 show that a band corresponding in size to the GFP RNA has been dramatically up-regulated in the sorted cell line (Fig. 4 , lane 5) compared to the parental control (Fig. 4, lane 3) . Actin primers were used to control for the amount of input RNA. Omission of reverse transcriptase eliminated the signal, indicating that the products were due to RNA (Fig. 4, lanes 2, 4, and 6 ). We conclude that at least a significant portion of the GFP up-regulation is at the RNA level. Increased IgH promoter activity in the selected high-GFP 2017 cells. Transient transfection studies revealed that the activity of the full-length 17.2.25 IgH promoter had increased relative to the octamer-containing H2B promoter in a subset of the selected clones. For example clones m2, m4, and h3 (Fig.  5A ) exhibited approximately fourfold-higher 17.2.25 IgH promoter activity than the parental 2017-IgH-GFP clone no. 9 cell line. In contrast, stable overexpression of human Oct-2 in this cell line did not induce increased promoter activity (data not shown). The murine pre-B-cell line 70Z/3, which displays relatively strong IgH promoter activity, was used as a positive control (Fig. 5A) . Interestingly, we also found that two other B-cell-specific promoters, B29/Ig␤/CD79b (Ϫ164 to ϩ32) and mb-1/Ig␣/CD79a (Ϫ252 to ϩ48) (gifts of R. Wall; for sequences, see Fig. 8 ) were up-regulated relative to the parental cell type (Fig. 5A) . In contrast, the activity of the pre-T-cell receptor ␣ promoter (a gift of B. Reizis) remained the same in all tested cell lines, suggesting that the increased activity is confined to B-cell-specific promoters (data not shown). These data indicate that multiple B-cell-specific promoters exhibit higher activity in the selected cell lines.
The increased GFP activity could reflect a more global potentiation of the activity of many IgH promoters. To test this possibility, we used a construct containing a different IgH promoter (V H 186.2, Ϫ230 to ϩ70) (20) (for the sequence, see Fig.  8 ) linked to the IgH intronic enhancer (EVH186.2) (a gift of F. Alt). We observed that this promoter was also up-regulated relative to the parental cell type (Fig. 5B) .
The IgH intronic enhancer appeared to remain largely inactive in the selected cell lines, as the ratio of activity of EVH186.2 to IgH-154 ϩ 35 was approximately the same as that of the parental line (Fig. 5B) . In contrast, the B-cell line 70Z/3 showed a dramatic increase in reporter activity when the construct with the enhancer was used. To more directly test this idea, we inserted the E sequence from EVH186.2 into the IgH-154 ϩ 35 construct by using a distal XbaI site (see Materials and Methods) and transfected this construct into the parental and selected 2017 cell lines. In this configuration, we observed a substantial increase in luciferase activity with the enhancer in 70Z/3 B cells, but a much more modest increase in activity with the parental 2017-IgH-GFP no. 9 cell line. While we observed an increase in reporter activity in two selected cell lines with both constructs, we did not observe any further up-regulation in the presence of the enhancer (Fig. 5C) . We conclude that the high-GFP 2017 cell lines have been altered in a manner that potentiates the activity of multiple IgH promoters, but IgH intronic enhancer activity is not augmented.
To determine which regions of the IgH 17.2.25 promoter were necessary for the up-regulation in the selected cell lines, constructs lacking either the downstream regions or the octamer motif were tested in transient transfection assays. Among the constructs used, only those that lacked the sequences downstream of the transcription initiation site eliminated the higher promoter activity in the selected high-GFP clones relative to the parental cell type (data not shown). Scanning promoter mutants were used in the selected cell lines to determine which regions were important for the up-regulation (Fig. 5D) . Mutations in ϩ16, ϩ17, and ϩ18 and mutations in ϩ19, ϩ20, and ϩ21 largely eliminated the increased promoter activity seen in the selected cells, indicating that this region was critical for the up-regulation. The mutant promoter constructs still retained significant activity over the backbone plasmid (not shown). Thus, the downstream sequences are a likely targets of the factor(s) mediating the up-regulation of promoter activity in the selected high-GFP cells.
High-density gene arrays were used to compare the mRNA expression profiles of the parental and two selected cell lines (m6 and h3), resulting in a list of 70 genes and expressed sequence tags whose expression coordinately changed by twofold or more (unpublished data). Notably absent from the list of genes with altered expression (but present on the array) were Oct-1, Oct-2, and OCA-B. Two up-regulated genes, as measured by the gene chip, were CD53 and L-selectin/MEL-14. We used commercial antibodies to stain for surface CD53 and L-selectin and analyzed the degree of expression using flow cytometry (Fig. 6) . CD53 was significantly up-regulated in the selected cell line m6 compared to the 2017-IgH-GFP no. 9 parental cell line (compare Fig. 6B with 6A ). L-selectin was up-regulated to a lesser extent, and in this case 2017-IgH-GFP no. 9 had a higher degree of baseline expression (compare Fig.  6F to 6E ). Increased nonspecific binding of the secondary antibodies could be excluded as a factor in these results, as omitting the primary antibody eliminated the signal (Fig. 6C,  D 4) , and the selected high-GFP clone h3 (lanes 5 and 6). Primers recognized the GFP reporter. Actin primers (Ambion) were used as a control. RT reactions were amplified using 24 cycles of PCR. Alternating lanes omitted reverse transcriptase as a control (Ϫ). GFP, amplification product corresponding to GFP; A, actin amplification product.
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( Fig. 6I ) and clone 6 (Fig. 6J) are also shown. These data suggest that the selected cell lines display an altered transcriptional profile compared to the parental cell line. Activation of endogenous IgH V region gene expression in selected cells. The IgH locus undergoes D-J recombination and sterile transcription with relatively high frequency in T-cell lines; however, V region recombination and sterile transcription are not commonly observed and are strictly off in 2017 cells (41) . Because the selected cell lines appear to have acquired a more-B-cell-like phenotype, it was possible that the endogenous Ig loci became activated. To test this possibility, we assayed for V H region transcriptional activity by using RT-PCR. We focused on the IgH region, which is the first to become activated and rearranged in B cells, because the 2017 variants were selected for higher IgH promoter activity. We used primers homologous to the major J558 family of V H regions. The 5Ј primer matched the leader sequence encoding the leader peptide, and the 3Ј primer was homologous to the conserved framework III region. The primers spanned an intron, allowing spliced transcripts to be distinguished from any contaminating DNA. The predicted size of the product corresponding to the spliced RNA was approximately 270 bp, whereas the signal due to contaminating DNA was predicted to be 340 bp. Actin primers were used to control the amount of RNA in the reaction mixture. The parental cell line and the mouse pre-B-cell line 70Z/3 were used as controls. As shown in Fig. 7 , no PCR product corresponding in size to the spliced RNA could be detected in 2017-IgH-GFP clone no. 9 (Fig. 7,  lane 1) . In contrast, reaction mixtures containing RNA from two different high-GFP-expressing clones contained a product , and 70Z/3 were also transfected. The histone H2B promoter was used as a control. pCMV-␤Gal was cotransfected, and the luciferase/␤-Gal ratios for the H2B construct were normalized to 1. The dark bars depict Ig promoter activity. Shaded bars are B29 and mb-1. Lipid-mediated transfection reagents were used. (B) Selected high-GFP cell lines 70Z/3 and 2017 and parent line 2017-IgH-GFP no. 9 were transiently transfected with either the 17.2.25 promoter (gray bars) or the V H 186.2 promoter with the IgH intronic enhancer upstream (white bars). pCMV-␤Gal was cotransfected, and luciferase/␤-Gal ratios are depicted on the y axis. Lipid-mediated transfection reagents were used. (C) Selected cell lines m4, h3, and 70Z/3, and the parental cell line 2017-IgH-GFP no. 9 were transiently transfected with either IgH-154 ϩ 35 (gray bars) or the same construct in which the intronic enhancer had been inserted (white bars) (see Materials and Methods). Lipid-mediated transfection reagents were used. pCMV-␤Gal was cotransfected as an internal control. Experiments were performed in triplicate, and error bars denote standard deviations. (D) Scanning promoter mutants were transiently transfected into either the parent cell line 2017-IgH-GFP no. 9 (gray bars) or the high-GFP-selected cell line m4 (white bars). Lipid-mediated transfection reagents were used. pCMV-␤Gal was cotransfected, and luciferase/␤-Gal ratios are depicted on the y axis. . Cell line 2017-IgH-GFP no. 9 (left panels) or the high-GFPselected clone m6 (right panels) were stained with biotinylated antibodies to CD53 (PharMingen) (A and B), L-selectin (PharMingen) (E and F), or phosphate-buffered saline as a negative control (C, D, G, and H). After being incubated and washed, the cells were incubated with streptavidin-allophycocyanin (APC) (panels A to H). Also shown in panels I and J are the GFP profiles for 2017-IgH-GFP no. 9 and h3, respectively. Note that the x axes are logarithmic.
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matching the size of spliced transcripts (Fig. 7, lanes 3 and 5) . As expected, these same transcripts were detected in 70Z/3 cells (Fig. 7, lane 7) . When reverse transcriptase was omitted from the reactions (Fig. 7 , even-numbered lanes), no RNA signal was detected. These results indicate that the endogenous IgH J558 V regions have become transcriptionally active to at least a limited extent.
DISCUSSION
We have identified sequences proximal to the transcription initiation site that have a role in strong cell-type-specific expression. Complete deletion of sequences between the initiation site and ϩ35 compromises promoter activity in B and selected T cells. Interestingly, the deletion was more deleterious in cell lines derived from later-stage B cells such as BJA-B than for earlier stage lines such as 70Z/3. Scanning promoter mutagenesis pinpointed the ϩ16 to ϩ18 region, as well as a region immediately upstream of the transcription initiation site, as being most important for the higher activity of BJA-B cells relative to the nonlymphoid WERI-27 cells. Grosschedl and colleagues (S. Hardy and R. Grosschedl, personal communication) have analyzed the -41 light chain promoter using deletion and mutagenesis. They also have found that sequences near and downstream of the transcription initiation site are important for strong promoter activity as assayed by in vitro transcription (Fig. 8) . Thus, analysis of two Ig promoters by using two different assay systems indicates that elements downstream of the transcription initiation site are important for controlling expression.
We have used an in vivo T-cell IgH transcription model to help elucidate new elements mediating high levels of IgH promoter expression. In this approach, 2017 cells carrying a 190-bp IgH promoter upstream of GFP were selected for high activity. This method was preferable to scoring the endogenous Ig locus because (i) the GFP activity was simple to assay and (ii) the protocol selects for higher activity of a relatively small promoter region rather than the megabase-scale endogenous IgH locus. The murine pre-T-cell line 2017 can autonomously modulate the activity of stable transfected IgH promoters, as no stimulus was given to the cells prior to sorting. In the first round of sorting, the top ϳ0.1% of cells were selected. Expanding this population and assaying the cells in a second round, we observed that approximately 4% of the cells sorted into a high-GFP window. Assuming slightly slower growth for the high-GFP cells, we estimate that 1 in 20,000 cells carries the high-GFP phenotype in the original population. Although the emergence of the high-GFP variants was spontaneous, the activity was stable even after long periods of culture. Other reports have documented the ability of T-cell lines to intrinsically modulate the expression of certain genes. For example, the cell line EL-4 can spontaneously turn on or off the expression of NK-related surface markers and other markers such as CD4 and CD44 (11) . In some cases, the changes were coordinate, as for example CD2 and CD3 would only change together.
The transfected 17.2.25 IgH promoter was more active in the selected cell lines. Scanning promoter mutagenesis experiments pinpointed the same region downstream of the transcription start site that was important for optimal B-cell expression in the up-regulation of promoter activity in the selected cells. This effect was investigated further by examining other promoters. In addition to two IgH promoters representing different VH family members (17.2.25 is a V H 81X/7183 family member and V H 186.2 is a member of the major J558 class), two other B-cell-specific promoters-B29 and mb-1-have increased activity in the selected cell lines relative to the parental cell lines and to the histone H2B promoter. In contrast, the pre-T-cell receptor ␣ promoter remained equally active (not shown).
The difference between the levels of expression of the immunoglobulin promoters in the selected clones versus the parental cell lines strongly indicates that the activities of specific transcription factors are different in the two populations. However, the degree of up-regulation of the transiently transfected 17.2.25 IgH promoter in the selected cell lines (3-to 5-fold) was much less than the degree of up-regulation of the inte- 8) . Primers recognized the J558 family of variable region gene segments. The 5Ј primer corresponded to the leader sequence, and the 3Ј primer corresponded to the framework III region. Actin primers (Ambion) were used as controls. Alternating lanes (Ϫ) omitted reverse transcriptase as a control. D, PCR product corresponding to amplification of contaminating DNA; R, shorter product corresponding to spliced mRNA; A, actin product.
VOL. 22, 2002 FUNCTIONAL ANALYSIS OF Ig PROMOTER ACTIVITYgrated promoter upstream of GFP (10-to 100-fold). This difference in the degree of transcriptional activation could be explained by differences in the chromatin state of the integrated and transiently transfected plasmids. A simple explanation for the increase in expression of the IgH promoter in the selected cells would be that a rare event changed the methylation state or chromatin structure of the stable transfected reporter. Several points argue against such a local mechanism. First, multiple different stable transfected clones of 2017-IgH-GFP can be selected to have high GFP activity, indicating that the position(s) of integration does not affect the up-regulation of the IgH promoter. Second, this same promoter and other B-cell-specific promoters are upregulated in the high-GFP cell lines when transiently transfected. In the case of the 17.2.25 IgH promoter, the up-regulation is sensitive to particular point mutations in transient transfection assays. Third, the endogenous IgH locus has apparently become activated in the selected cell lines (see below), suggesting a common function of specific trans factors at different chromosomal locations. Fourth, a gene chip indicates that a number of genes have an altered expression in the selected cell lines (Fig. 6 and unpublished data) .
Interestingly, the 17. sulted in no significant overall homology. However, the highest scoring alignments corresponded to the areas identified in the different screens (data not shown). This finding indicates that the two sequence elements may be functionally related. We examined several other promoters from both the heavy and light chain V region genes of both mice and humans for similar sequences (Fig. 8) . Many of these sequences contain obvious pyrimidine-rich sequences, typically downstream of the transcription initiation site. Although we chose promoters with minimal overall similarity to one another, all Ig V regions presumably derived from genetic duplication of an ancestral prototype, and thus aligning these promoters may highlight identity by descent. However, a Gibbs sampling algorithm (22) designed to detect conserved motifs distributed within a set of sequences produced a 14-nucleotide consensus when provided with the sequences shown in Fig. 8 . The consensus is shown at the bottom of Fig. 8 , and the top 25 perfect and near matches to the consensus (all of which are 9 of 14 nucleotides or better) are boxed. When the nucleotide sequences were scrambled, the algorithm did not produce a meaningful consensus. The derived sequence appears to consist of two half sites, one that is T/G rich and one that is A/C rich, with a pyrimidine-rich sequence in between them. Importantly, the nucleotide residues implicated in promoter expression by mutational analysis in the 17.2.25 heavy chain and -41 light chain promoters (Fig.  8) overlapped with consensus sequences. We propose that factors recognizing this consensus sequence mediate higher promoter activity in B cells and in the selected T-cell lines. The biological significance of these sequences is buttressed by the finding that downstream nucleotides from the 186.2 promoter, containing the two boxed elements shown in Fig. 8 , can restore full promoter activity to the Ϫ154 to ϩ1 segment of the 17.2.25 promoter.
The endogenous IgH locus became activated in several of the selected cell lines, as RT-PCR showed the presence of spliced J558 V region transcripts. Although it is formally possible that the transcripts are derived from a recombined mature IgH mRNA, it is unlikely given the lack of activation of the IgH intronic enhancer in the selected cell lines and the lack of activation of constant region genes present on a murine 11,000-molecular-weight gene chip (11K gene chip). We have also been unable to detect IgH recombination in DNA prepared from the selected cell lines by PCR (data not shown). More likely, these RT-PCR products represent germ line transcripts. Stable expression of the Ig intronic enhancer-binding transcription factor E47 in 2017 has been shown to activate limited recombination and sterile transcription of the D-J regions, but not the V regions, of the IgH locus (42) . Therefore, high-GFP selection of a 2017-IgH-GFP cell line expressing E47 could initiate IgH production. Such a system would provide an experimental platform by which to study factors that activate the IgH locus in a T-cell line.
The octamer motif was originally identified through its high conservation in Ig promoters (9, 34) . Subsequently, the octamer was found in other non-B-cell-specific genes, appearing to rule it out as a specificity element. The description of B-cellspecific complexes forming on octamer elements, later shown to be due to Oct-2 (21, 40, 47, 52), rekindled the debate over octamer specificity. More recently, B cells derived from Oct-2 homozygous null mice were shown to be capable of expressing Ig. The coactivator OCA-B was also shown to be dispensable (19, 32, 43) .
One explanation for these results is that an as yet unidentified cofactor mediates B-cell specificity through the octamer, possibly in conjunction with the ubiquitous factor Oct-1. Another possibility is that the octamer motif is not the sole mediator of Ig promoter activity or B-cell specificity. There is ample evidence to support this idea. A number of Ig heavy and light chain V region promoters lack consensus octamer sites and do not interact with Oct proteins in vitro but are nevertheless efficiently expressed (2) . In one such promoter, activity was shown to be mediated by a pyrimidine-rich element termed Y. Eaton and Calame also noted the presence of a pyrimidine-rich region in many Ig promoters, in this case upstream of the octamer and heptamer motifs (8) . In their study, mutation of this element was as deleterious to the activity of the promoter as point mutation of the octamer. A similar sequence occurs upstream of the octamer in the 17.2.25 promoter used in these studies (centered at Ϫ105). Roeder and colleagues have used chimeric constructs containing portions of an IgH and the H2B promoter. Their data indicate that the determinants of promoter specificity lie not with the octamer sequence but with the core promoter (R. Roeder, personal communication). In support of this idea, we have found that nuclear extracts prepared from the selected high-GFP 2017 cells show an increased ability to form a specific nucleoprotein complex at the IgH core promoter relative to extracts from the unselected cell line (D. Tantin and P. A. Sharp, unpublished data).
Proteins that interact with promoter DNA proximal to and downstream of the transcription initiation site have been described previously. TFIID, for example, forms an extended footprint containing multiple downstream DNA contacts to approximately ϩ35 on the adenovirus major late promoter (31) . These contacts are especially important for promoter activity in the case of promoters with nonconsensus TATA regions (as with the IgH promoter), and they can be sequence specific (18) . More recently, sequence-specific downstream promoter elements have been described for Drosophila and mammals (4) . Current work is aimed at determining the nature of the factors that interact with these new Ig promoter elements.
